Concepedia

Yale Mitchel

YM

56

Publications

4.5K

Citations

35

H-Index

1987

Active since

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

Louisville Metabolic and Atherosclerosis Research Center

Baylor College of Medicine

National Clinical Research

Center for Clinical Research (United States)

Yale Mitchel is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in medicine, cardiovascular disease, and pharmacology.

Top concepts

Publications per year

1987–2023

56

Publications

56

Safety of Anacetrapib in Patients with or at High Risk for Coronary Heart Disease

Christopher P. Cannon, Sukrut Shah, Hayes M. Dansky et al. · New England Journal of Medicine · 2010 · 746 citations · Full text

Efficacy and safety of the cholesteryl ester transfer protein inhibitor anacetrapib as monotherapy and coadministered with atorvastatin in dyslipidemic patients

Daniel M. Bloomfield, Gary L. Carlson, Aditi Sapre et al. · American Heart Journal · 2008 · 242 citations

, , +6

Atherothrombotic Risk Stratification and Ezetimibe for Secondary Prevention

Erin A. Bohula, David A. Morrow, Robert P. Giugliano et al. · Journal of the American College of Cardiology · 2017 · 196 citations

, , +7

Efficacy and Safety of Ezetimibe Coadministered With Simvastatin in Patients With Primary Hypercholesterolemia: A Randomized, Double-Blind, Placebo-Controlled Trial

Anne C. Goldberg, Aditi Sapre, Ji Liu et al. · Mayo Clinic Proceedings · 2004 · 193 citations

, , +9

Reduction of Cardiovascular Events by Simvastatin in Nondiabetic Coronary Heart Disease Patients With and Without the Metabolic Syndrome

Kalevi Pyörälà, Christie M. Ballantyne, Barry Gumbiner et al. · Diabetes Care · 2004 · 168 citations · Full text

Rows per page

1–5 of 56